Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2019 Filed Dec 3, 2019 21:31 UTC |
WAY JOHNChief Financial Officer
|
Tax withholdingCommon Stock | 195 | $95.83 | $18,686.85 |
DisclosureSEC source: 0001437749-19-023807 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,299 F1 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 190 shares purchased on May 15, 2018, 74 shares purchased on November 15, 2018, 118 shares purchased on May 15, 2019, and 91 shares purchased on November 15, 2019 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 22:27 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,381 | $0.00 Strike: $30.58 | $0.00 |
DisclosureSEC source: 0001437749-19-022511 · rdgdoc.xml · derivative · entry 2 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,381 Underlying: Common Stock · 2,381 shares Expires 2022-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 22:27 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 2,381 | $30.58 | $72,810.98 |
DisclosureSEC source: 0001437749-19-022511 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:17 UTC |
Chin MoonhieDirector
|
GrantCommon Stock | 990 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-015466 · rdgdoc.xml · nonDerivative · entry 1 Chin Moonhie · CIK 0001395001 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 990 Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:39 UTC |
Black Archie C.Director
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-010410 · rdgdoc.xml · nonDerivative · entry 1 Black Archie C. · CIK 0001489095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,112 F1 · shares: The deferred stock units vest in full on May 16, 2020, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:38 UTC |
Gawlick RainerDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-010408 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,300 F1 · shares: The deferred stock units vest in full on May 16, 2020, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:39 UTC |
Goodman John BDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-010409 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,389 F1 · shares: The deferred stock units vest in full on May 16, 2020, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:37 UTC |
WEHRWEIN SVENDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-010407 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,189 F1 · shares: The deferred stock units vest in full on May 16, 2020, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:36 UTC |
Chand SujeetDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-010406 · rdgdoc.xml · nonDerivative · entry 1 Chand Sujeet · CIK 0001388884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,547 F1 · shares: The deferred stock units vest in full on May 16, 2020, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 15, 2019 Filed May 17, 2019 20:31 UTC |
KRANTZ DONALD GDirector
|
GrantCommon Stock | 1,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-010404 · rdgdoc.xml · nonDerivative · entry 1 KRANTZ DONALD G · CIK 0001183159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,547 F1 · shares: The restricted stock units vest in full on the earlier of May 15, 2020 or the date of the Company's 2020 annual meeting of shareholders. Read SEC document |
| May 04, 2019 Filed May 7, 2019 20:44 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Tax withholdingCommon Stock | 252 | $110.55 | $27,858.60 |
DisclosureSEC source: 0001437749-19-009002 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,123 Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:50 UTC |
HOLT VICTORIA MDirector · President and CEO
|
Tax withholdingCommon Stock | 2,459 | $108.47 | $266,727.73 |
DisclosureSEC source: 0001437749-19-002749 · rdgdoc.xml · nonDerivative · entry 1 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,702 Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:49 UTC |
WAY JOHNChief Financial Officer
|
Tax withholdingCommon Stock | 1,435 | $108.47 | $155,654.45 |
DisclosureSEC source: 0001437749-19-002748 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,021 Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 20:48 UTC |
FEIN DAVID MChief Revenue Officer
|
Tax withholdingCommon Stock | 688 | $108.47 | $74,627.36 |
DisclosureSEC source: 0001437749-19-002747 · rdgdoc.xml · nonDerivative · entry 1 FEIN DAVID M · CIK 0001626274 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,009 Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:10 UTC |
HOLT VICTORIA MDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,120 | $0.00 Strike: $104.99 | $0.00 |
DisclosureSEC source: 0001437749-19-002467 · rdgdoc.xml · derivative · entry 2 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,120 Underlying: Common Stock · 7,120 shares Expires 2029-02-11 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:10 UTC |
HOLT VICTORIA MDirector · President and CEO
|
GrantCommon Stock | 6,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-002467 · rdgdoc.xml · nonDerivative · entry 1 HOLT VICTORIA M · CIK 0001181629 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,161 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:08 UTC |
Baker Arthur R. IIIChief Technology Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,204 | $0.00 Strike: $104.99 | $0.00 |
DisclosureSEC source: 0001437749-19-002463 · rdgdoc.xml · derivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,204 Underlying: Common Stock · 3,204 shares Expires 2029-02-11 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:08 UTC |
Baker Arthur R. IIIChief Technology Officer
|
GrantCommon Stock | 2,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-002463 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,375 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:09 UTC |
WAY JOHNChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 4,806 | $0.00 Strike: $104.99 | $0.00 |
DisclosureSEC source: 0001437749-19-002466 · rdgdoc.xml · derivative · entry 2 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,806 Underlying: Common Stock · 4,806 shares Expires 2029-02-11 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:09 UTC |
WAY JOHNChief Financial Officer
|
GrantCommon Stock | 4,244 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-002466 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,456 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:09 UTC |
FEIN DAVID MChief Revenue Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,670 | $0.00 Strike: $104.99 | $0.00 |
DisclosureSEC source: 0001437749-19-002465 · rdgdoc.xml · derivative · entry 2 FEIN DAVID M · CIK 0001626274 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,670 Underlying: Common Stock · 2,670 shares Expires 2029-02-11 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:09 UTC |
FEIN DAVID MChief Revenue Officer
|
GrantCommon Stock | 2,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-002465 · rdgdoc.xml · nonDerivative · entry 1 FEIN DAVID M · CIK 0001626274 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,697 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:06 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,136 | $0.00 Strike: $104.99 | $0.00 |
DisclosureSEC source: 0001437749-19-002459 · rdgdoc.xml · derivative · entry 2 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,136 Underlying: Common Stock · 2,136 shares Expires 2029-02-11 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:06 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
GrantCommon Stock | 1,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-002459 · rdgdoc.xml · nonDerivative · entry 1 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,704 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:07 UTC |
Bodor RobertVP/General Manager-Americas
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,204 | $0.00 Strike: $104.99 | $0.00 |
DisclosureSEC source: 0001437749-19-002461 · rdgdoc.xml · derivative · entry 2 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,204 Underlying: Common Stock · 3,204 shares Expires 2029-02-11 F2 · derivative.exercise_date: The option vests as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:07 UTC |
Bodor RobertVP/General Manager-Americas
|
GrantCommon Stock | 2,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-19-002461 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,584 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:05 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 700 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001437749-19-002458 · rdgdoc.xml · derivative · entry 2 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 700 shares Expires 2019-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:05 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 700 | $5.56 | $3,892.00 |
DisclosureSEC source: 0001437749-19-002458 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2018 Filed Dec 19, 2018 21:17 UTC |
WAY JOHNChief Financial Officer
|
Tax withholdingCommon Stock | 291 | $126.93 | $36,936.63 |
DisclosureSEC source: 0001437749-18-022307 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,212 Read SEC document |
| December 01, 2018 Filed Dec 20, 2018 18:11 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
Tax withholdingCommon Stock | 477 | $126.93 | $60,545.61 |
DisclosureSEC source: 0001437749-18-022354 · rdgdoc.xml · nonDerivative · entry 1 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,818 Read SEC document |
| October 24, 2018 Filed Oct 24, 2018 20:23 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 800 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001437749-18-018696 · rdgdoc.xml · derivative · entry 4 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700 Underlying: Common Stock · 800 shares Expires 2019-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| October 24, 2018 Filed Oct 24, 2018 20:23 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 800 | $5.56 | $4,448.00 |
DisclosureSEC source: 0001437749-18-018696 · rdgdoc.xml · nonDerivative · entry 2 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2018 Filed Oct 24, 2018 20:23 UTC |
Gawlick RainerDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 800 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001437749-18-018696 · rdgdoc.xml · derivative · entry 3 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 800 shares Expires 2019-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| October 22, 2018 Filed Oct 24, 2018 20:23 UTC |
Gawlick RainerDirector
|
Exercise / conversionCommon Stock | 800 | $5.56 | $4,448.00 |
DisclosureSEC source: 0001437749-18-018696 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 20:27 UTC |
WAY JOHNChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $57.88 | $0.00 |
DisclosureSEC source: 0001437749-18-017487 · rdgdoc.xml · derivative · entry 6 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,185 Underlying: Common Stock · 3,000 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2018. The transactions reported on this Form 4 conclude the transactions contemplated by the Rule 10b5-1 trading plan. F6 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2017. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 20:27 UTC |
WAY JOHNChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $67.15 | $0.00 |
DisclosureSEC source: 0001437749-18-017487 · rdgdoc.xml · derivative · entry 5 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,995 Underlying: Common Stock · 5,000 shares Expires 2025-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2018. The transactions reported on this Form 4 conclude the transactions contemplated by the Rule 10b5-1 trading plan. F5 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2016. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 20:27 UTC |
WAY JOHNChief Financial Officer
|
SaleCommon Stock | 4,644 | $160.14 | $743,691.55 |
DisclosureSEC source: 0001437749-18-017487 · rdgdoc.xml · nonDerivative · entry 4 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,503 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2018. The transactions reported on this Form 4 conclude the transactions contemplated by the Rule 10b5-1 trading plan. F4 · price: Reflects the weighted average price of 4,444 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 24, 2018 with sale prices ranging from $160.00 to $160.30 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 20:27 UTC |
WAY JOHNChief Financial Officer
|
SaleCommon Stock | 3,356 | $157.66 | $529,104.61 |
DisclosureSEC source: 0001437749-18-017487 · rdgdoc.xml · nonDerivative · entry 3 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,147 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2018. The transactions reported on this Form 4 conclude the transactions contemplated by the Rule 10b5-1 trading plan. F3 · price: Reflects the weighted average price of 3,356 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 24, 2018 with sale prices ranging from $157.50 to $158.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 20:27 UTC |
WAY JOHNChief Financial Officer
|
Exercise / conversionCommon Stock | 3,000 | $57.88 | $173,640.00 |
DisclosureSEC source: 0001437749-18-017487 · rdgdoc.xml · nonDerivative · entry 2 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2018. The transactions reported on this Form 4 conclude the transactions contemplated by the Rule 10b5-1 trading plan. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 20:27 UTC |
WAY JOHNChief Financial Officer
|
Exercise / conversionCommon Stock | 5,000 | $67.15 | $335,750.00 |
DisclosureSEC source: 0001437749-18-017487 · rdgdoc.xml · nonDerivative · entry 1 WAY JOHN · CIK 0001626832 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2018. The transactions reported on this Form 4 conclude the transactions contemplated by the Rule 10b5-1 trading plan. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:08 UTC |
Goodman John BDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 536 | $0.00 Strike: $70.00 | $0.00 |
DisclosureSEC source: 0001437749-18-017162 · rdgdoc.xml · derivative · entry 5 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 536 shares Expires 2025-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:08 UTC |
Goodman John BDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 577 | $0.00 Strike: $62.68 | $0.00 |
DisclosureSEC source: 0001437749-18-017162 · rdgdoc.xml · derivative · entry 4 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 577 shares Expires 2024-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:08 UTC |
Goodman John BDirector
|
SaleCommon Stock | 1,113 | $162.95 | $181,364.91 |
DisclosureSEC source: 0001437749-18-017162 · rdgdoc.xml · nonDerivative · entry 3 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,078 F2 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. F3 · price: Reflects the weighted average price of 1,113 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 14, 2018 with sale prices ranging from $162.95 to $163.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:08 UTC |
Goodman John BDirector
|
Exercise / conversionCommon Stock | 536 | $70.00 | $37,520.00 |
DisclosureSEC source: 0001437749-18-017162 · rdgdoc.xml · nonDerivative · entry 2 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 20:08 UTC |
Goodman John BDirector
|
Exercise / conversionCommon Stock | 577 | $62.68 | $36,166.36 |
DisclosureSEC source: 0001437749-18-017162 · rdgdoc.xml · nonDerivative · entry 1 Goodman John B · CIK 0001321965 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2018. Read SEC document |
| September 04, 2018 Filed Sep 11, 2018 19:46 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,474 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001437749-18-016849 · rdgdoc.xml · derivative · entry 3 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,211 Underlying: Common Stock · 3,474 shares Expires 2026-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on May 4, 2017. Read SEC document |
| September 04, 2018 Filed Sep 11, 2018 19:46 UTC |
Baker Arthur R. IIIChief Technology Officer
|
SaleCommon Stock | 3,474 | $154.81 | $537,815.15 |
DisclosureSEC source: 0001437749-18-016849 · rdgdoc.xml · nonDerivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,546 F1 · price: Reflects the weighted average price of 3,474 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 4, 2018 with sale prices ranging from $154.55 to $155.10 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 04, 2018 Filed Sep 11, 2018 19:46 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Exercise / conversionCommon Stock | 3,474 | $60.96 | $211,775.04 |
DisclosureSEC source: 0001437749-18-016849 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 20:51 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 907 | $0.00 Strike: $58.35 | $0.00 |
DisclosureSEC source: 0001437749-18-016526 · rdgdoc.xml · derivative · entry 5 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,628 Underlying: Common Stock · 907 shares Expires 2027-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. F5 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2018. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 20:51 UTC |
Bodor RobertVP/General Manager-Americas
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,528 | $0.00 Strike: $78.59 | $0.00 |
DisclosureSEC source: 0001437749-18-016526 · rdgdoc.xml · derivative · entry 4 Bodor Robert · CIK 0001581088 · VP/General Manager-Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,632 Underlying: Common Stock · 3,528 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2018. F4 · derivative.exercise_date: The option vests as to 20% of the shares in five annual installments beginning on February 13, 2015. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.